
    
      Aim of the study

        1. To assess the difference in patients' clinical status improvement between patients
           receiving remdesivir alone and patients receiving remdesivir and lopinavir/ ritonavir.

        2. To detect time to improvement in oxygenation among both groups.

        3. To detect duration of hospitalization and mortality rate in both groups.

        4. To detect incidence and duration of mechanical ventilation in both treatment arms.

        5. To monitor of adverse events of both drugs.
    
  